Company intelligence / Profile preview

Target RWE

Durham, North Carolina, United Statestargetrwe.com ↗

Ownership: Private
Employees: ~120
Development stage: Commercial

Overview

Target RWE is an industry-leading real-world evidence solutions provider that generates high-quality longitudinal datasets and advanced analytics to support pharmaceutical development, regulatory submissions, post-marketing surveillance, and health economics research. Their proprietary registries have supported new drug development and label expansion opportunities in the US and Europe. The company's collaborative academic model has led to impactful scientific publications influencing treatment guidelines.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Amgen Inc.Norwest Venture PartnersVentureSouthFDA collaboration on real-world evidence projectsAcademic partnerships via HCV-TARGET consortium22C Capital

Beyond the preview

Go deeper on Target RWE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Target RWE.

Explore the full profile